313
Views
12
CrossRef citations to date
0
Altmetric
Research Article

PPARγ disease gene network and identification of therapeutic targets for prostate cancer

, , , , &
Pages 781-796 | Received 04 Feb 2011, Accepted 24 Feb 2011, Published online: 23 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Babita Shashni, Kishore R. Sakharkar, Yukio Nagasaki & Meena K. Sakharkar. (2013) Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology. Journal of Drug Targeting 21:2, pages 161-174.
Read now

Articles from other publishers (11)

Yuyuan Chen, Lvjun Cen, Rong Guo, Sheng Huang & Dedian Chen. (2022) Roles and mechanisms of phosphoglycerate kinase 1 in cancer. Bulletin du Cancer 109:12, pages 1298-1307.
Crossref
Marta Vuerich, Na Wang, Jonathon J. Graham, Li Gao, Wei Zhang, Ahmadreza Kalbasi, Lina Zhang, Eva Csizmadia, Jason Hristopoulos, Yun Ma, Efi Kokkotou, Adam S. Cheifetz, Simon C. Robson & Maria Serena Longhi. (2022) Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease. Communications Biology 5:1.
Crossref
Renald Blundell, Jean Claude Grech & Muhammad Ajmal Shah. 2021. Nutraceuticals and Cancer Signaling. Nutraceuticals and Cancer Signaling 145 178 .
Abid Bhat, Arehally M. Mahalakshmi, Bipul Ray, Sunanda Tuladhar, Tousif A. Hediyal, Esther Manthiannem, Jagadeeswari Padamati, Ramesh Chandra, Saravana B. Chidambaram & Meena K. Sakharkar. (2019) Benefits of curcumin in brain disorders. BioFactors 45:5, pages 666-689.
Crossref
Victoria Obermoser, Margarethe E. Urban, Manuela S. Murgueitio, Gerhard Wolber, Ulrich Kintscher & Ronald Gust. (2016) New telmisartan-derived PPARγ agonists: Impact of the 3D-binding mode on the pharmacological profile. European Journal of Medicinal Chemistry 124, pages 138-152.
Crossref
Qing Tang, JingJing Wu, Fang Zheng, YuQing Chen & Swei Sunny Hann. (2016) WITHDRAWN: Emodin increases expression of insulin-like growth factor binding protein 1 through activation of MEK/ERK/AMPKα and interaction of PPARγ and Sp1 in lung cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Crossref
Farzad S. Forootan, Shiva S. Forootan, Xiaojun Gou, Jin Yang, Bichong Liu, Danqing Chen, Majed Saad Al Fayi, Waseem Al-Jameel, Philip S. Rudland, Syed A. Hussain & Youqiang Ke. (2016) Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter . Oncotarget 7:8, pages 9322-9339.
Crossref
Li Zhang & Handong Wang. (2015) Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin. Marine Drugs 13:7, pages 4310-4330.
Crossref
Hanumantharayappa Bharathkumar, Shardul Paricharak, K. R. Dinesh, Kodappully Sivaraman Siveen, Julian E. Fuchs, Shobith Rangappa, C. D. Mohan, Nima Mohandas, Alan Prem Kumar, Gautam Sethi, Andreas Bender, Basappa Basappa & K. S. Rangappa. (2014) Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-?. RSC Adv. 4:85, pages 45143-45146.
Crossref
Meena K. Sakharkar, Babita Shashni, Karun Sharma, Sarinder K. Dhillon, Prabhakar R. Ranjekar & Kishore R. Sakharkar. (2013) Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer. PPAR Research 2013, pages 1-11.
Crossref
Sakshi Sikka, Luxi Chen, Gautam Sethi & Alan Prem Kumar. (2012) Targeting PPAR γ Signaling Cascade for the Prevention and Treatment of Prostate Cancer . PPAR Research 2012, pages 1-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.